These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 15793148

  • 1. Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods.
    Cantón E, Pemán J, Gobernado M, Viudes A, Espinel-Ingroff A.
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1593-6. PubMed ID: 15793148
    [Abstract] [Full Text] [Related]

  • 2. Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
    Quindós G, Sánchez-Vargas LO, Villar-Vidal M, Eraso E, Alkorta M, Hernández-Almaraz JL.
    Int J Antimicrob Agents; 2008 Mar; 31(3):266-71. PubMed ID: 18054468
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of voriconazole against Candida species isolated in Taiwan.
    Yang YL, Cheng HH, Lo HJ.
    Int J Antimicrob Agents; 2004 Sep; 24(3):294-6. PubMed ID: 15325436
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of fluconazole and voriconazole against clinical isolates of Candida spp. by E-test method.
    Madhavan P, Jamal F, Chong PP, Ng KP.
    Trop Biomed; 2010 Aug; 27(2):200-7. PubMed ID: 20962716
    [Abstract] [Full Text] [Related]

  • 5. Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation.
    Kronvall G, Karlsson I.
    J Clin Microbiol; 2001 Apr; 39(4):1422-8. PubMed ID: 11283066
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001.
    Pfaller MA, Diekema DJ, Messer SA, Boyken L, Hollis RJ.
    J Clin Microbiol; 2003 Apr; 41(4):1440-6. PubMed ID: 12682127
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven tertiary hospitals in São Paulo state, Brazil.
    Purisco SU, Martins MA, Szeszs MW, Castro e Silva DM, Pukinskas SR, Bonfietti LX, Baez AA, Melhem MS.
    FEMS Yeast Res; 2012 Dec; 12(8):890-6. PubMed ID: 22883021
    [Abstract] [Full Text] [Related]

  • 16. Comparison of disk diffusion test and Etest for voriconazole and fluconazole susceptibility testing.
    Buchta V, Vejsova M, Vale-Silva LA.
    Folia Microbiol (Praha); 2008 Dec; 53(2):153-60. PubMed ID: 18837162
    [Abstract] [Full Text] [Related]

  • 17. Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.
    Nguyen MH, Yu CY.
    J Antimicrob Chemother; 1998 Aug; 42(2):253-6. PubMed ID: 9738846
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Susceptibility to fluconazole and voriconazole of Candida species isolated from intensive care units patients in Medellin, Colombia (2001-2007)].
    Rodríguez AZ, Gómez Cde B, Restrepo CA, Parra HH, Arteaga MA, Moreno AR, Marín AG.
    Rev Iberoam Micol; 2010 Sep 30; 27(3):125-9. PubMed ID: 20450982
    [Abstract] [Full Text] [Related]

  • 20. Effects of voriconazole, granulocyte-macrophage colony-stimulating factor, and interferon gamma on intracellular fluconazole-resistant Candida glabrata and Candida krusei in human monocyte-derived macrophages.
    Baltch AL, Bopp LH, Smith RP, Ritz WJ, Carlyn CJ, Michelsen PB.
    Diagn Microbiol Infect Dis; 2005 Aug 30; 52(4):299-304. PubMed ID: 15893901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.